$121.07 arrow  Change: 0.65 %Chge: 0.54% Vol: 71,856
End Of Day Prices
High: 121.65 | Low: 120.76 | Open: 120.76 | Close: 121.07
52 Wk High: 149 | 52 Wk Low: 96.65 | Todays Pivot: 121.16
Sector: Healthcare and Pharmaceuticals add stock to watch list

ALXN Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Brookdale Sr Living 12.005 green arrow 794,410
Mylan 23.55 red arrow 427,173
Laboratory Amer Hldgs 142.33 green arrow 21,091
Humana 231.73 green arrow 107,820
Valeant Pharmaceuticals Intl I 13.275 red arrow 1,327,668
Patterson Companies 46.16 green arrow 47,100
Boston Scientific 13.175 green arrow 823,430
Cooper 94.94 red arrow 17,875

Above is a small selection of related companies to Alexion Pharmaceuticals which compete alongside ALXN within the Healthcare and Pharmaceuticals sector. To see more related companies to ALXN, view our stock market today information page.

Online News For Alexion Pharmaceuticals

Alexion Pharmaceuticals (ALXN) Lifted to "Outperform" at Robert W. Baird

(NYSE:V), 33 have Buy rating, 0 Sell and 7 Hold. Therefore 29% are positive. The stock of Yamana Gold Inc. (NYSE:V) has "Outperform" rating given on Tuesday, November 3 by RBC Capital Markets. The stock has a market capitalization of $27,140.00, a P/E ...

Alexion Pharmaceuticals (ALXN) Stock Rating Upgraded by BidaskClub

Bender Robert & Associates now owns 32,873 shares of the biopharmaceutical company's stock valued at $3,931,000 after purchasing an additional 430 shares in the last quarter. Corda Investment Management Llc who had been investing in Chevron Corp Com for a ...

Alexion Pharmaceuticals, Inc. (ALXN) Expected to Announce Earnings of $1.28 Per Share

The institutional investor held 40,469 shares of the health care company at the end of 2017Q3, valued at $5.62 million, up from 25,513 at the end of the previous reported quarter. About 4.42M shares traded. Harmony Gold Mining Company Limited (NYSE:HMY ...

ALXN March 2nd Options Begin Trading

Investors in Alexion Pharmaceuticals Inc. (Symbol: ALXN) saw new options become available today, for the March 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALXN options chain for the new March 2nd contracts ...

Alexion Pharmaceuticals (ALXN) Stock Rating Reaffirmed by Raymond James Financial

After $1.28 actual earnings per share reported by Alexion Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -15.63% negative EPS growth. Amundi Pioneer Asset Management Inc has 0.03% invested in Alexion Pharmaceuticals, Inc. The ...

Want To Add This Quote To Your Site?

With our stock widgets you can add a Alexion Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ALXN to choose from. Visit here to build your stock quote widget »